ENTITY

Personalis Inc (PSNL US)

7
Analysis
Health Care • United States
Personalis, Inc. provides genomic sequencing and analytics solutions. The Company supports the development of personalized cancer vaccines and other next-generation cancer immunotherapies. Personalis serves customers worldwide.
more
Exchange Announcement • 07 Oct 2026 04:07

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Exchange Announcement • 07 Oct 2026 04:05

Current Report (Form 8-K | Period ending 2026-10-02)

Exchange Announcement • 16 Sep 2026 05:25

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Exchange Announcement • 21 Aug 2026 04:46

Current Report (Form 8-K | Period ending 2026-08-20)

Exchange Announcement • 04 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

x